Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) Sees Large Increase in Short Interest

Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) was the target of a significant increase in short interest during the month of February. As of February 15th, there was short interest totalling 900 shares, an increase of 800.0% from the January 31st total of 100 shares. Based on an average trading volume of 2,400 shares, the days-to-cover ratio is currently 0.4 days.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Trading Down 0.3 %

HROWM traded down $0.08 during midday trading on Thursday, reaching $26.61. 1,538 shares of the company’s stock traded hands, compared to its average volume of 2,915. The firm has a fifty day moving average of $26.48 and a two-hundred day moving average of $26.42. Harrow Health, Inc. 11.875% Senior Notes due 2027 has a 52 week low of $25.30 and a 52 week high of $27.72.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Cuts Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, January 31st. Stockholders of record on Wednesday, January 15th were given a $0.7422 dividend. This represents a $2.97 annualized dividend and a dividend yield of 11.16%. The ex-dividend date was Wednesday, January 15th.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Company Profile

harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.